Imaging drug delivery to the lungs: Methods and applications in oncology-Reference-Cited by-同舟云学术

Imaging drug delivery to the lungs: Methods and applications in oncology

Published:2023-01 Issue: Volume:192 Page:114641
ISSN:0169-409X
Container-title:Advanced Drug Delivery Reviews
language:en
Short-container-title:Advanced Drug Delivery Reviews

Author:

Man Francis,Tang Jie,Swedrowska Magda,Forbes Ben,T.M. de Rosales Rafael

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference266 articles.

1. Office for National Statistics, Cancer survival by stage at diagnosis for England, 2019. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/cancersurvivalratescancersurvivalinenglandadultsdiagnosed.

2. Drug delivery to the lungs: challenges and opportunities;Newman;Ther. Deliv.,2017

3. Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities;Mangal;Acta Pharmacol. Sin.,2017

4. Hepatic Arterial Infusion Versus Systemic Therapy for Hepatic Metastases From Colorectal Cancer: A Randomized Trial of Efficacy, Quality of Life, and Molecular Markers (CALGB 9481);Kemeny;J. Clin. Oncol.,2006

5. An Update on the Use of Intraperitoneal Chemotherapy in the Management of Ovarian Cancer;Markman;Cancer J.,2009

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preparation of antibody-loaded protein microbeads for pulmonary delivery via Shirasu porous glass membrane emulsification and freeze drying;Journal of Drug Delivery Science and Technology;2024-06

2. Automated Restarting Fast Proximal Gradient Descent Method for Single-View Cone-Beam X-ray Luminescence Computed Tomography Based on Depth Compensation;Bioengineering;2024-01-26

3. Image-Guided Drug Delivery: Biomedical and Imaging Advances;Advanced Drug Delivery Reviews;2024-01

4. Pulmonary delivery of nano‐particles for lung cancer diagnosis and therapy: Recent advances and future prospects;WIREs Nanomedicine and Nanobiotechnology;2023-10-19

5. Strategies for overcoming the biological barriers associated with the administration of inhaled monoclonal antibodies for lung diseases;Expert Opinion on Drug Delivery;2023-08-03